CAS: 943609-66-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Vedolizumab REF: TM-T9914CAS: 943609-66-3 | SDS-PAGE:98.4%;SEC-HPLC:99.1% | 185.00 €~2,037.00 € | Tue 17 Dec 24 |
 | Vedolizumab REF: 3D-BV165597CAS: 943609-66-3 | Min. 95% | To inquire | Mon 27 Jan 25 |
Vedolizumab
CAS:943609-66-3
Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of …
Purity:
SDS-PAGE:98.4%;SEC-HPLC:99.1%
Color and Shape:
Liquid
Molecular weight:
146.80 kDa
Ref: TM-T9914
| 1mg | 185.00 € | ||
| 5mg | 503.00 € | ||
| 10mg | 727.00 € | ||
| 25mg | 1,103.00 € | ||
| 50mg | 1,486.00 € | ||
| 100mg | 2,037.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Vedolizumab
CAS:943609-66-3
Inhibits lymphocyte adhesion to mucosal endothelium; Crohn's disease therapy
Purity:
Min. 95%
Ref: 3D-BV165597
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 250µg | To inquire | ||
| 500µg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
